Versuchen GOLD - Frei

BioSpectrum Asia - BioSpectrum Asia January 2024

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Lesen BioSpectrum Asia zusammen mit über 9.000 anderen Zeitschriften und Zeitungen mit nur einem Abonnement

Katalog anzeigen

1 Monat

$14.99

1 Jahr $149.99

$149.99

$12/month

(OR)

Abonnieren Sie nur BioSpectrum Asia

Geschenk BioSpectrum Asia

Jederzeit kündbar.

(Keine Verpflichtungen) ⓘ

Sollten Sie mit Ihrem Abonnement nicht zufrieden sein, senden Sie uns innerhalb von 7 Tagen nach Abonnementbeginn eine E-Mail an help@magzter.com, um eine vollständige Rückerstattung zu erhalten. Versprochen! (Hinweis: Gilt nicht für den Kauf einzelner Ausgaben.)

Digitales Abonnement

Sofortiger Zugriff ⓘ

Abonnieren Sie jetzt, um sofort mit dem Lesen auf der Magzter-Website sowie in den iOS-, Android- und Amazon-Apps zu beginnen.

Verifiziert sicher

zahlen ⓘ

Magzter ist ein verifizierter Authorize.Net-Händler. Weitere Informationen

In dieser Ausgabe

Transformative Life Sciences Trends for 2024 The intersection of tech and healthcare holds immense potential for the life sciences industry. From generative artificial intelligence (GenAI), augmented reality (AR), and virtual reality (VR) to decentralised clinical trials and 3D printing, we delve into the latest tech trends such Cellular Multi-Omics, Gene Editing CRISPR Technologies, Decentralised Clinical Trial (DCTs), digital health, digital twins, smart manufacturing, and wearables poised to lead the life sciences landscape in 2024.

INDIA'S CDMO ASCENSION

We are ushering in 2024 with a good development for the Indian pharmaceutical sector.

3 mins

Australia launches first National Health & Climate Strategy

The Australian government has launched Australia's first National Health and Climate Strategy that is aimed at ensuring the health system can meet the challenges of climate change.

1 mins

Taiwan partners with US to develop digital health ecosystem

The Healthcare Information and Management Systems Society, US and the National Health Insurance Administration (NHIA), an agency under the Ministry of Health and Welfare of Taiwan, have formed an agreement to drive digital transformation in population health, digital capacity building, cybersecurity resilience and workforce development.

1 mins

WHO & India ink Traditional and Complementary Medicine Project Collaboration Agreement'

The Ministry of Ayush, Government of India, and World Health Organization (WHO) have signed a Traditional and Complementary Medicine 'Project Collaboration Agreement' in Geneva.

1 mins

NZ to design cancer control programme

New Zealand’s Ministry of Health’s Polynesian Health Corridors (PHC) programme is working with partners to design a multi-year cancer control programme to improve cancer outcomes in Polynesia.

1 mins

MTal unveils India's historic $464M medtech FDI leap

India has witnessed a recordbreaking surge of $464 million in foreign investments in medtech in the first 3 quarters, said the Medical Technology Association of India (MTI), which represents leading researchbased medical technology companies with a large footprint in manufacturing and training in India.

1 mins

ADB provides $650M to support upgrading Indonesia's healthcare facilities and labs

The Asian Development Bank (ADB) has approved a $650 million investment loan to Indonesia to upgrade and enhance primary healthcare facilities and public health laboratories nationwide to improve prevention, detection, and treatment of communicable diseases, non-communicable diseases, and other health conditions

1 mins

GHIT Fund injects $8.8M in new drug development projects for malaria

The Global Health Innovative Technology (GHIT) Fund, headquartered in Japan, has announced an investment of approximately 1.3 billion yen ($8.8 million) for the development of new drugs for malaria and Chagas disease

1 mins

GC Biopharma establishes mRNA production facility in Korea

GC Biopharma, a South Korean biopharmaceutical company, has completed the construction of mRNA (messenger ribonucleic acid) production facility in its own vaccine production plant in Hwasun, Jeollanam-do, Korea, and will soon start the operation.

1 mins

Nipro partners with FPT Medicare to develop IOMT in Vietnam

Nipro, a multinational medical corporation from Japan, has recently partnered with Vietnam-based FPT Telecom's FPT Medicare on a strategic cooperation agreement to deliver digital medical devices with international standards and affordability.

1 mins

China's MGI Tech takes cutting-edge DNA, Cell and Spatial Omics capabilities to Australia

MGI Australia, a subsidiary of China headquartered MGI Tech Co., a global leader in life science technology, has announced a substantial expansion of its Brisbane Customer Experience Centre (CEC), now providing Australian and New Zealand researchers first access to MGI's cutting-edge DNA, Cell and Spatial Omics (DCS) capabilities.

1 mins

Singapore's Experimental Drug Development Centre inks new collaboration with Chinese startup XtalPi

XtalPi, an innovative technology company powered by artificial intelligence (AI) and robotics from China, has signed a Memorandum of Understanding (MoU) with the Experimental Drug Development Centre (EDDC), Singapore's national drug discovery and development platform hosted by A*STAR, for the expansion of their collaboration to encompass potential projects that will focus on the application of automated synthesis solutions and large language models in pharmaceutical research.

1 mins

Fujitsu delivers advanced technology to Delight Health for treating delirium

Japan-based Fujitsu and Delight Health, a Bay Area startup, have announced that Fujitsu will licence its Topological Data Analysis (TDA) technology to Delight Health in exchange for an equity position in the company.

1 mins

WHO's Science Council issues report on mRNA vaccine technology

Prompted by the life-saving impact of messenger ribonucleic acid (mRNA) vaccines during the COVID-19 pandemic, the World Health Organization's Science Council has released a report reviewing the potential benefits and limitations of mRNA vaccine technology.

1 mins

US FDA approves first gene therapies to treat patients with sickle cell disease

The US Food and Drug Administration (FDA) has approved two milestone treatments, Casgevy (Vertex Pharmaceuticals Inc.) and Lyfgenia (Bluebird Bio Inc.), representing the first cell-based gene therapies for the treatment of sickle cell disease (SCD) in patients 12 years and older.

1 mins

Transformative Life Sciences Trends for 2024

The intersection of tech and healthcare holds immense potential for the life sciences industry.

10+ mins

Digitalisation Pharma Tech Trends to look for in 2024

As companies look ahead to 2024 trends, those that are well prepared for the future will not ignore technology and digitalisation trends, but rather find new and valuable ways to leverage them.

2 mins

Tech Trends for Life Sciences to Watch in 2024

Trends to watch in the life sciences industry are ones that support personalised, preventative healthcare, including high quality collection of samples, and the trends in data analysis resulting from the sensitive measurements of thousands of molecules by LC-MS/MS.

2 mins

Targeted Battle Against HPV

Since the launch of the global strategy against cervical cancer in 2020, the World Health Organization (WHO) has accelerated the initiative by virtue of commitments and strategies offered by governments and organisations worldwide.

6 mins

Combating AMR with Bacteriophages

India is among the countries with a high burden of antibiotic-resistant infections.

7 mins

"The Open Innovation Program has become a trend in the molecular diagnostics industry"

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins.

5 mins

What's Propelling mRNA Therapies Today?

Over the next three to five years, it is anticipated that the portfolio of mRNA treatments and vaccines will grow significantly due to the potential that mRNA has across indications.

6 mins

Lesen Sie alle Geschichten von BioSpectrum Asia

BioSpectrum Asia Description:

Herausgeber: MM-Activ-Sci-Tech-Communication

Kategorie: Business

Sprache: English

Frequenz: Monthly

BioSpectrum Asia Magazine is a monthly magazine published by MM Activ Sci-Tech Communication in India. It is a leading biotechnology magazine in Asia, covering a wide range of topics related to the biotechnology industry, including:

* Biotechnology news and trends: BioSpectrum Asia covers the latest biotechnology news and trends from India and around the world.

* Biotechnology company profiles and interviews: The magazine profiles leading biotechnology companies in Asia and interviews their CEOs and other top executives.

* Biotechnology research and development: BioSpectrum Asia covers the latest biotechnology research and development from academic institutions and pharmaceutical companies.

* Biotechnology product reviews: The magazine reviews the latest biotechnology products and services.

* Biotechnology industry events: BioSpectrum Asia covers biotechnology industry events from around the world.

BioSpectrum Asia Magazine is a must-read for anyone who wants to stay informed about the latest advances in biotechnology and their potential to impact the world around us.